Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hubei Sanxin Biotechnology Co., Ltd. is a Chinese biotechnology company specialized in the research, development, and high-volume production of natural plant extracts and pharmaceutical raw materials. Founded in 2011 and based in Shiyan, Hubei, the company is a recognized national high-tech enterprise that integrates scientific research, large-scale planting, and global sales. Its core product portfolio includes high-purity bioactive compounds such as resveratrol, chlorogenic acid, polydatin, and puerarin, as well as liposomal formulations for enhanced bioavailability. With an annual production capacity exceeding 800 tons and extensive GAP-certified planting bases, Sanxin serves the pharmaceutical, nutraceutical, and cosmetic sectors across more than 30 countries. The company maintains rigorous quality standards, holding certifications such as GMP, ISO9001, and FDA registration.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sanxin Biotechnology.